Authors:
Jackson, KA
Rosenbaum, SE
Kerr, BM
Pithavala, YK
Yuen, G
Dudley, MN
Citation: Ka. Jackson et al., A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial, ANTIM AG CH, 44(7), 2000, pp. 1832-1837
Citation: Ka. Jackson et Se. Rosenbaum, The application of population pharmacokinetics to the drug development process, DRUG DEV IN, 24(12), 1998, pp. 1155-1162